SK2382002A3 - Drug for treating fractures - Google Patents

Drug for treating fractures Download PDF

Info

Publication number
SK2382002A3
SK2382002A3 SK238-2002A SK2382002A SK2382002A3 SK 2382002 A3 SK2382002 A3 SK 2382002A3 SK 2382002 A SK2382002 A SK 2382002A SK 2382002 A3 SK2382002 A3 SK 2382002A3
Authority
SK
Slovakia
Prior art keywords
bone
medicament
bisphosphonate
group
administered
Prior art date
Application number
SK238-2002A
Other languages
English (en)
Slovak (sk)
Inventor
David G Little
Original Assignee
Royal Alexandra Hosp Children
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Royal Alexandra Hosp Children filed Critical Royal Alexandra Hosp Children
Publication of SK2382002A3 publication Critical patent/SK2382002A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK238-2002A 1999-08-19 2000-08-17 Drug for treating fractures SK2382002A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ2325A AUPQ232599A0 (en) 1999-08-19 1999-08-19 Drug for treating fractures
PCT/AU2000/000982 WO2001013922A1 (en) 1999-08-19 2000-08-17 Drug for treating fractures

Publications (1)

Publication Number Publication Date
SK2382002A3 true SK2382002A3 (en) 2002-09-10

Family

ID=3816500

Family Applications (1)

Application Number Title Priority Date Filing Date
SK238-2002A SK2382002A3 (en) 1999-08-19 2000-08-17 Drug for treating fractures

Country Status (16)

Country Link
EP (1) EP1214079A4 (no)
JP (1) JP2003507426A (no)
KR (1) KR20020027562A (no)
CN (1) CN100345548C (no)
AU (1) AUPQ232599A0 (no)
BR (1) BR0013416A (no)
CA (1) CA2381302A1 (no)
HK (1) HK1048441B (no)
HU (1) HUP0202396A3 (no)
IL (1) IL148166A0 (no)
NO (1) NO20020784L (no)
NZ (1) NZ517538A (no)
PL (1) PL353485A1 (no)
SK (1) SK2382002A3 (no)
WO (1) WO2001013922A1 (no)
ZA (1) ZA200202160B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ527351A (en) 2001-02-06 2005-01-28 Royal Alexandra Hosp Children Use of bisphosphonate for the treatment of osteonecrosis and for the management of patients at risk of developing ostenonecrosis
WO2002080933A1 (en) * 2001-04-03 2002-10-17 The Royal Alexandra Hospital For Children A drug for use in bone grafting
AUPR553701A0 (en) * 2001-06-07 2001-07-12 Royal Alexandra Hospital For Children, The A device for the delivery of a drug to a fractured bone
EP1508343B1 (en) * 2003-08-21 2015-11-04 AddBIO AB Bisphosponate coated implant device and method therefor
RU2326695C2 (ru) * 2003-09-19 2008-06-20 Пфайзер Продактс Инк. Фармацевтические композиции и способы, включающие комбинации 2-алкилиденовых производных 9-нор-витамина d и бисфосфоната
ITMI20040218A1 (it) * 2004-02-10 2004-05-10 Abiogen Pharma Spa Uso di neridronato sodico per promuovere la neoformazione ossea
ITMI20040641A1 (it) * 2004-03-31 2004-06-30 Tb Technology S R L Composizioni bioadesive bifunzionali per implantologia orale
AR048742A1 (es) * 2004-12-22 2006-05-24 Gador Sa Sistema de aplicacion de medicamentos intra-oral
JP5426168B2 (ja) * 2005-10-27 2014-02-26 トーメン メディカル アーゲー 歯科インプラント及びその製造方法
US8882740B2 (en) 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR8107560A (pt) * 1981-11-19 1983-07-05 Luiz Romariz Duarte Estimulacao ultra-sonica da consolidacao de fraturas osseas
RU2112515C1 (ru) * 1991-12-17 1998-06-10 Проктер энд Гэмбл Фармасьютикалз, Инк. Способ лечения остеопороза
AU670337B2 (en) * 1992-11-30 1996-07-11 Novartis Ag Use of certain methanebisphosphonic acid derivatives in fracture healing
EP0600834A1 (en) * 1992-11-30 1994-06-08 Ciba-Geigy Ag Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
AU5953894A (en) * 1992-12-23 1994-07-19 Merck & Co., Inc. Bisphosphonate/estrogen therapy for treating and preventing bone loss
US5403829A (en) * 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
US5646134A (en) * 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
US5616571A (en) * 1995-06-06 1997-04-01 Merck & Co., Inc. Bisphosphonates prevent bone loss associated with immunosuppressive therapy
AU703887B2 (en) * 1995-06-06 1999-04-01 Merck & Co., Inc. Bisphosphonate therapy for bone loss associated with rheumatoid arthritis
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
GB9613722D0 (en) * 1996-06-28 1996-08-28 Univ Liverpool Chemical compounds

Also Published As

Publication number Publication date
ZA200202160B (en) 2003-08-27
PL353485A1 (en) 2003-11-17
WO2001013922A1 (en) 2001-03-01
HK1048441B (zh) 2008-02-22
HUP0202396A3 (en) 2005-02-28
CN100345548C (zh) 2007-10-31
EP1214079A1 (en) 2002-06-19
KR20020027562A (ko) 2002-04-13
CN1370071A (zh) 2002-09-18
NZ517538A (en) 2003-07-25
CA2381302A1 (en) 2001-03-01
AUPQ232599A0 (en) 1999-09-09
NO20020784D0 (no) 2002-02-18
IL148166A0 (en) 2002-09-12
HK1048441A1 (en) 2003-04-04
BR0013416A (pt) 2002-04-30
JP2003507426A (ja) 2003-02-25
HUP0202396A2 (hu) 2002-11-28
NO20020784L (no) 2002-02-18
EP1214079A4 (en) 2004-03-24

Similar Documents

Publication Publication Date Title
WO2002098307A1 (en) A device for the delivery of a drug to a fractured bone
US20040157798A1 (en) Drug for use in bone grafting
JPH09512268A (ja) 整形外科的人工器官移植後の骨吸収を阻害するためのビスホスホネートの使用
EP0758241B1 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
Tudor et al. Static and dynamic periosteal elevation: a pilot study in a pig model
US10046082B2 (en) Collagen sponge containing a drug for promoting fracture healing and method for preparing the same
AU2002244520A1 (en) A drug for use in bone grafting
Pampu et al. Experimental evaluation of the effects of zoledronic acid on regenerate bone formation and osteoporosis in mandibular distraction osteogenesis
WO1996039107A1 (en) Bisphosphonate cement composition to prevent aseptic loosening of orthopedic implant devices
SK2382002A3 (en) Drug for treating fractures
Tarvainen et al. Effect of clodronate on fracture healing in denervated rats
JP2024037985A (ja) 人工骨膜
Harding et al. A single dose zoledronic acid enhances pin fixation in high tibial osteotomy using the hemicallotasis technique. A double-blind placebo controlled randomized study in 46 patients
ES2247842T3 (es) Uso de ibandronato para promover la oseo-integracion de endoprotesis.
AU781068B2 (en) Drug for treating fractures
Schortinghuis et al. Does ultrasound stimulate osteoconduction? A placebo-controlled single-blind study using collagen membranes in the rat mandible
Saghieh et al. The impact of zoledronic acid on regenerate and native bone after consolidation and removal of the external fixator: an animal model study
RU2816809C1 (ru) Способ прагматизации репаративного остеогенеза трубчатых костей животных
RU2250789C2 (ru) Способ лечения повреждений костей при замедленной консолидации
RU2469679C1 (ru) Способ сочетанной стимуляции репаративного остеогенеза у животных
Heidari et al. Effect of risedronate on bone resorption during the consolidation phase of distraction osteogenesis: a rabbit model
Green et al. Postoperative Care, Day by Day
Martin et al. Callus distraction in reconstructive foot surgery
Alsandook et al. Histological Evaluation of Tissues Using a Bone Inducing Substance in Cases of Micro-Screw Implant
RU2002106871A (ru) Лекарственный препарат для лечения переломов

Legal Events

Date Code Title Description
FC9A Refused patent application